These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Excessive Catecholamine Secretion and the Activation of the Renin-Angiotensin-Aldosterone-System in Patients with Pheochromocytoma: A Single Center Experience and Overview of the Literature. Haase M; Dringenberg T; Allelein S; Willenberg HS; Schott M Horm Metab Res; 2017 Oct; 49(10):748-754. PubMed ID: 28837972 [TBL] [Abstract][Full Text] [Related]
49. [The application of captopril challenge test in the diagnosis of primary aldosteronism]. Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038 [No Abstract] [Full Text] [Related]
50. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case. Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321 [No Abstract] [Full Text] [Related]
51. Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism. Vetter H; Appenheimer M; Lucas R; Weiand H; Herschbach ML; Glänzer K; Witassek F; Krück F Horm Res; 1977; 8(1):23-8. PubMed ID: 892704 [TBL] [Abstract][Full Text] [Related]
52. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240 [TBL] [Abstract][Full Text] [Related]
53. Plasma renin activity and intrarenal blood flow distribution in a child with a pheochromocytoma. Hiner LB; Gruskin AB; Baluarte HJ; Cote ML; Sapire DW; Levitsky D J Pediatr; 1976 Dec; 89(6):950-2. PubMed ID: 993920 [No Abstract] [Full Text] [Related]
54. A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone. Adachi J; Hirai Y; Terui K; Nakano T; Fukuda Y; Suda T; Sasano H Intern Med; 2003 Aug; 42(8):714-8. PubMed ID: 12924498 [TBL] [Abstract][Full Text] [Related]
55. Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours. Zacharieva S; Atanassova I; Orbetzova M; Nachev E; Kalinov K; Kirilov G; Shigarminova R; Ivanova R; Dashev G Eur J Endocrinol; 2004 Mar; 150(3):345-9. PubMed ID: 15012620 [TBL] [Abstract][Full Text] [Related]
56. [Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North]. Iakovlev VA; Sokol LIu; Karlov VA Klin Med (Mosk); 1998; 76(1):35-7. PubMed ID: 9532913 [TBL] [Abstract][Full Text] [Related]
57. [The renin-angiotension-aldosterone system and cortisol excretion before, during and after enflurane anaesthesia for orthopaedic surgery (author's transl)]. Hack G; Pless V; Vetter H Anasth Intensivther Notfallmed; 1980 Dec; 15(6):453-9. PubMed ID: 7013558 [No Abstract] [Full Text] [Related]
58. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma. Mune T; Morita H; Yasuda K; Yamakita N; Miura K J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449 [TBL] [Abstract][Full Text] [Related]
60. Interaction of noradrenaline and dopamine in patients with essential hypertension or with pheochromocytoma. Yoshimura M; Ikegaki I; Fukuyama M; Nishimura M; Takahashi H Clin Exp Hypertens A; 1989; 11 Suppl 1():397-402. PubMed ID: 2743600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]